Experienced leadership... building successful diagnostics and life sciences companies
Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm.
Maravai’s mission is to build a transformative company in the in vitro diagnostics and life sciences tools markets by acquiring outstanding businesses in these spaces and accelerating their growth. We do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.
We are seeking to acquire established, high-quality businesses with the following characteristics:
◼ operations focused primarily in the IVD products, diagnostic laboratory services or life sciences tools markets;
◼ leadership positions in their principal operating segments, driven by either proprietary products or services; and,
◼ clear revenue growth opportunities and the associated operating cash flows, with operating earnings generally in excess of $15 million annually.
Please feel free to contact us directly to discuss opportunities to work together.